Andere Sprachen Hikma Pharmaceuticals PLC

Aktien

A0HG69

GB00B0LCW083

HIK

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:29 27.06.2024			% 5 Tage	% 1. Jan.
1 875 ^GBX	-2,19 %		-6,25 %	+4,81 %

24.06.	Teva bringt generische Version des Diabetes-Medikaments Victoza von Novo Nordisk auf den Markt	RE
20.06.	Fitch bestätigt Ratings und Ausblick für Hikma Pharmaceuticals aufgrund der 'defensiven Marktposition'	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Teva launches generic version of Novo Nordisk's diabetes drug Victoza	24.06.
Fitch Confirms Ratings, Outlook on Hikma Pharmaceuticals on 'Defensive Market Position'	20.06.
Xellia Pharmaceuticals to focus on the manufacturing and commercialization of its life-saving anti-infectives portfolio through its global B2B partners	18.06.
Hikma acquires Xellia s differentiated portfolio and enhances Injectables pipeline, manufacturing capabilities and R&D	18.06.
Hikma adds scale to US injectables business with Xellia acquisition	17.06.
Hikma to Buy Xellia Pharmaceuticals Assets for $135 Million	17.06.
Astra gets US drug approval; Ascential trades in line	17.06.
Hikma Pharmaceuticals PLC agreed to acquire Finished Dosage Form Business and Assets of Xellia Pharmaceuticals for approximately $190 million.	17.06.
Morgan Stanley cuts Anglo American	11.06.
Egypt, UAE talks continuing over Ras El Hekma land deal	28.05.
HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum	17.05.
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	03.05.
HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets	26.04.
Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	25.04.
Hikma Pharmaceuticals : Special Business passed at AGM	25.04.
Hikma Pharmaceuticals backs outlook after making strong start to 2024	25.04.
Hikma Pharmaceuticals Affirms FY24 Guidance	25.04.
Hikma Pharmaceuticals PLC Proposes Final Dividend for the Full Year 2023	25.04.
Hikma Pharmaceuticals plc Reiterates Earnings Guidance for the Year 2024	25.04.
Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business	16.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

HIKMA PHARMACEUTICALS : Zeit, von Hikmas anhaltendem (Kurs-)Schwung zu profitieren

Am 17. Mai 2024 um 15:10 Uhr